Sustainability | 20 February 2024
Biocon included in S&P Global Sustainability Yearbook 2024
Sustainability is integral to Biocon's business purpose
Sustainability is integral to Biocon's business purpose
This recognition attests to Sun Pharma’s commitment to incorporate Environmental, Social, and Governance (ESG) principles through focused initiatives across its businesses
Ecolab’s continued leadership position on renowned sustainability indices demonstrates the company’s record of advancing sustainable growth
High-quality baobab oil sourced in collaboration with UNCCD and the Great Green Wall Initiative
The new ECO grade is made using renewable feedstock
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
The target boundary includes biogenic land?related emissions and removals from bioenergy feedstock
For the year 2022, Biocon bettered its score in all the four EcoVadis themes – Environment (70), Labor & Human Rights (70), Ethics (60), and Sustainable Procurement (60)
Greenko ZeroC will supply Carbon Free Energy and enable Green Hydrogen along with its various chemical derivatives.
The project will generate and supply green energy to fulfill about 50% present consumption of the company
Value chain collaboration aims to foster a circular ecosystem and reduce the carbon footprint of single-use surgical instruments molded in Ixef PARA.
Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%
Cumulatively, almost 75% of the health centres in the country have been electrified with a cumulative solar capacity of 3.5 MW
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
Pfizer aims to achieve net-zero targets ten years earlier than the expectations of the Net-Zero Standard
Report lays out blueprint for achieving Organon’s purpose and business imperatives to help women and girls achieve their promise through better health
By 2025, the company plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry
When asked how to balance ESG with broader business goals, the panel was unanimous in its assessment that ESG is ‘good for business’
This agreement is truly remarkable for achieving greater objectives in the projects and addressing larger problems
Subscribe To Our Newsletter & Stay Updated
